- Home
- ATOS vs INVE Comparison
ATOS vs INVE Comparison
Compare ATOS & INVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- INVE
- Stock Information
- Founded
- ATOS 2009
- INVE 1990
- Country
- ATOS United States
- INVE United States
- Employees
- ATOS N/A
- INVE N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- INVE Computer peripheral equipment
- Sector
- ATOS Health Care
- INVE Technology
- Exchange
- ATOS Nasdaq
- INVE Nasdaq
- Market Cap
- ATOS 106.9M
- INVE 90.9M
- IPO Year
- ATOS 2012
- INVE 1997
- Fundamental
- Price
- ATOS $0.77
- INVE $3.31
- Analyst Decision
- ATOS Strong Buy
- INVE Strong Buy
- Analyst Count
- ATOS 3
- INVE 2
- Target Price
- ATOS $6.25
- INVE $5.50
- AVG Volume (30 Days)
- ATOS 539.9K
- INVE 52.5K
- Earning Date
- ATOS 11-12-2025
- INVE 11-10-2025
- Dividend Yield
- ATOS N/A
- INVE N/A
- EPS Growth
- ATOS N/A
- INVE N/A
- EPS
- ATOS N/A
- INVE N/A
- Revenue
- ATOS N/A
- INVE $22,015,000.00
- Revenue This Year
- ATOS N/A
- INVE N/A
- Revenue Next Year
- ATOS N/A
- INVE $9.06
- P/E Ratio
- ATOS N/A
- INVE N/A
- Revenue Growth
- ATOS N/A
- INVE N/A
- 52 Week Low
- ATOS $0.55
- INVE $2.86
- 52 Week High
- ATOS $1.36
- INVE $4.29
- Technical
- Relative Strength Index (RSI)
- ATOS 34.80
- INVE 37.80
- Support Level
- ATOS $0.77
- INVE $3.14
- Resistance Level
- ATOS $0.85
- INVE $3.77
- Average True Range (ATR)
- ATOS 0.05
- INVE 0.24
- MACD
- ATOS -0.01
- INVE -0.07
- Stochastic Oscillator
- ATOS 18.62
- INVE 11.83
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About INVE Identiv Inc.
Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has one reportable segment: the IoT Business segment. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific.